Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
06Oct2025
  • Home
  • About
  • News
  • Subscribe
06Oct2025
Cost Curve NewsCost Curve News
Cost Curve News

Roche Is Considering ‘Pharm to Table’ as a Weapon to Use Against Middlemen

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

‘Pseudo-Pharmas’ Are Getting Bigger … and Getting Creative When It Comes to Pricing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

J&J Publishes Its Annual Transparency Report, Discloses It Gave Back 58% of Sales in Rebates, Discounts, and Fees

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

NIH Cuts Would Mean Dozens of New Drugs Could Be Lost, CBO Says. That’s Probably an Undercount

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

A Congressional Examination of Pharm-to-Table Deals Offers Zero Surprises

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

BMS and Pfizer Plant the Seed for an Eliquis Pharm-to-Table Program

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

Trump Says Tariffs Are Coming Within Weeks, Prompting Next to No Reaction from Anyone

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

More Evidence that 340B Is Siphoning Billions from the Government

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

It’s Deadline Day: Trump’s First Drug-Related Executive Order Calls for Action on Middlemen and Importation

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
Cost Curve News

Forget What Happened Last Week: PBM Reform Looks Very Much Alive

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 months ago
Keep Reading
567

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

October 1, 2025

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

September 30, 2025

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

September 29, 2025

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,632)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,696)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,607)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,489)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,471)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe